<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02477085</url>
  </required_header>
  <id_info>
    <org_study_id>AAP-2014-030</org_study_id>
    <nct_id>NCT02477085</nct_id>
  </id_info>
  <brief_title>Methods of Labor Induction and Perinatal Outcomes</brief_title>
  <acronym>MEDIP</acronym>
  <official_title>Methods of Labor Induction and Perinatal Outcomes : a Prospective National Study in France</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Agence Nationale de sécurité du Médicament</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Since it is a frequent intervention in Obstetrics, labor induction is rarely evaluated from&#xD;
      national population-based cohorts. The study aims to assess the frequency of different&#xD;
      induction methods used in France from a prospective population-based cohort of women with an&#xD;
      induced labor. Maternal, fetal and neonatal outcomes will be compared between the different&#xD;
      induction methods. Moreover the adhesion to national clinical guidelines concerning the&#xD;
      induction of labor will be studied from this population-based cohort.&#xD;
&#xD;
      Finally the women satisfaction will be assessed according to the induction method used.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Labor induction concerns about 22% of deliveries in France, according to the the 2010 French&#xD;
      national perinatal survey. Labor induction could be associated with a higher risk of fetal&#xD;
      and maternal complications, justifying its assessment from a population-based prospective&#xD;
      cohort.&#xD;
&#xD;
      Several methods (dinoprostone, oxytocin, misoprostol, balloon catheter …) are used to induce&#xD;
      labor in France. To decide and perform labor inductions, physicians can refer to published&#xD;
      guidelines according to specific obstetrical situations. But many of these guidelines are&#xD;
      based on a low level of evidence probably explaining observed differences in practices.&#xD;
&#xD;
      In some cases, labor induction is decided without indication, and women's involvement in this&#xD;
      kind of decisions is not really evaluated.&#xD;
&#xD;
      The objectives are therefore :&#xD;
&#xD;
        -  To evaluate the frequency of use of different methods for labor induction according to&#xD;
           the cervix status, the indication of labor induction, and the place of the delivery.&#xD;
&#xD;
        -  To analyse maternal, fetal and neonatal issues according to the different induction&#xD;
           methods, taken into account the induction indications&#xD;
&#xD;
        -  To compare current practices of labor induction to published national guidelines and to&#xD;
           assess the impact of deviations from these guidelines on maternal and neonatal issues&#xD;
&#xD;
        -  To assess women's satisfaction regarding the indication and the induction method used.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Composite measure of induction methods</measure>
    <time_frame>Beginning of labor induction</time_frame>
    <description>Amniotomy&#xD;
Amniotomy and oxytocin&#xD;
Prostaglandins (PGE1, PGE2)&#xD;
Balloon catheter&#xD;
For each of these methods, evaluation of these composite criteria&#xD;
Frequency&#xD;
Posology&#xD;
Way of administration&#xD;
Indication of labor induction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Composite measure of maternal morbidity</measure>
    <time_frame>Labor induction</time_frame>
    <description>Systemic infection&#xD;
Uterine hyperkinesia&#xD;
Uterine hypertonia&#xD;
Instrumental delivery&#xD;
Caesarean section&#xD;
Degrees of perineal lacerations&#xD;
Surgical complications&#xD;
Uterine rupture&#xD;
Manual removal of the placenta&#xD;
Postpartum haemorrhage&#xD;
Anaemia&#xD;
Maternal transfer in ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite measure of fetal and neonatal mortality and morbidity</measure>
    <time_frame>from induction up to average 7 days post delivery</time_frame>
    <description>Fetal heart rate anomalies during labor&#xD;
Apgar score&#xD;
Acidosis (pH &lt; 7.10)&#xD;
Intubation&#xD;
Surfactant treatment administration&#xD;
Non-invasive ventilation&#xD;
Cardiopulmonary resuscitation&#xD;
Adrenaline administration&#xD;
Neonatal mortality&#xD;
Neonatal trauma (fracture of long bones or skull, brachial plexus elongation, injury of the spinal cord, subdural hematoma)&#xD;
Neonatal transfer in ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Women's satisfaction Questionnaire</measure>
    <time_frame>8 weeks after delivery</time_frame>
    <description>18 questions about :&#xD;
Woman's implication in the decision of labor induction&#xD;
Woman's comprehension about the reason of labor induction&#xD;
Woman's satisfaction about the decision/labor/delivery</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">3049</enrollment>
  <condition>Induction of Labor</condition>
  <arm_group>
    <arm_group_label>all women with an induced labor</arm_group_label>
    <description>prospective population-based cohort of all women who have an induced labor during one month in seven perinatal networks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>all women with an induced labor</intervention_name>
    <description>all women who have an induced labor</description>
    <arm_group_label>all women with an induced labor</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        all women who have an induced labor&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient who has a labor induction&#xD;
&#xD;
          -  with a live fetus at the beginning of induction&#xD;
&#xD;
          -  patient who did not have any opposition to use her medical and personal data or her&#xD;
             child's medical data for research&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  in utero fetal death&#xD;
&#xD;
          -  termination of pregnancy&#xD;
&#xD;
          -  patient's refusal to participate to the study&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Camille Le Ray</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance publique des Hôpitaux de Paris (APHP)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>François Goffinet</last_name>
    <role>Study Director</role>
    <affiliation>Assistance publique des Hôpitaux de Paris (APHP)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Port-Royal maternity unit, Cochin Hospital, Assistance publique des Hôpitaux de Paris (APHP</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>June 10, 2015</study_first_submitted>
  <study_first_submitted_qc>June 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 22, 2015</study_first_posted>
  <last_update_submitted>July 9, 2018</last_update_submitted>
  <last_update_submitted_qc>July 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Labor</keyword>
  <keyword>induction</keyword>
  <keyword>delivery</keyword>
  <keyword>prostaglandins</keyword>
  <keyword>oxytocin</keyword>
  <keyword>amniotomy</keyword>
  <keyword>balloon catheter</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

